Jiangsu Hengrui Medicine
600276.SS
#495
Rank
$40.47 B
Marketcap
$6.34
Share price
-0.78%
Change (1 day)
1.44%
Change (1 year)
Jiangsu Hengrui Medicine Company Limited is a Chinese pharmaceutical company engaged in the R&D, manufacturing and sales of healthcare products, including antineoplastic drugs, angiomyocardiac drugs, drugs for surgery, contrast agents and antibiotics

Jiangsu Hengrui Medicine (600276.SS) - Net assets

Net assets on the balance sheet as of September 2023 : $5.61 B

According to Jiangsu Hengrui Medicine 's latest financial reports the company has $5.61 B in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Jiangsu Hengrui Medicine - Net assets on balance sheet (from 2001 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$5.56 B-0.23%
2021-12-31$5.58 B18.26%
2020-12-31$4.72 B32.23%
2019-12-31$3.56 B23.21%
2018-12-31$2.89 B18.23%
2017-12-31$2.45 B32.18%
2016-12-31$1.85 B16.02%
2015-12-31$1.59 B21.36%
2014-12-31$1.31 B19.73%
2013-12-31$1.09 B25.99%
2012-12-31$0.87 B25.3%
2011-12-31$0.69 B32.57%
2010-12-31$0.52 B34.69%
2009-12-31$0.39 B31.31%
2008-12-31$0.29 B30.93%
2007-12-31$0.22 B39.77%
2006-12-31$0.16 B18.21%
2005-12-31$0.13 B13.76%
2004-12-31$0.12 B10.49%
2003-12-31$0.10 B11.66%
2002-12-31$97.85 M6.85%
2001-12-31$91.58 M